Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial

Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

Natural-killer cells and dendritic cells: „l’union fait la force“

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

Chaperone-rich cell lysates, immune activation and tumor vaccination

Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function

Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity

Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma

Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells